{"id":383919,"date":"2020-11-18T08:08:41","date_gmt":"2020-11-18T13:08:41","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=383919"},"modified":"2020-11-18T08:08:41","modified_gmt":"2020-11-18T13:08:41","slug":"enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/","title":{"rendered":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD,  TO ITS BOARD OF DIRECTORS"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, NY, Nov.  18, 2020  (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cthe Company\u201d), a leading biosciences and diagnostics company, announced today that Mary Tagliaferri, MD, has been appointed to the company\u2019s Board of Directors effective immediately.\u00a0\u00a0\u00a0 <\/p>\n<p align=\"justify\">\u201cIn 2020, Enzo reported significant progress in advancing our business plan to achieve profitability including strong results in many areas of our operations that position us for new levels of growth and momentum in 2021,\u201d said Dr. Elazar Rabbani, Ph.D., Enzo\u2019s Chairman and Chief Executive Officer.\u00a0 \u201cDr. Tagliaferri is a highly-respected industry leader with broad global experience in a range of operational areas including business development, clinical research and development, world-wide regulatory matters and medical affairs. \u00a0She will play a central role in our continued success and future growth at Enzo.\u201d<\/p>\n<p align=\"justify\">Dr. Tagliaferri is currently Executive Clinical Fellow and Senior Vice President and she was previously Chief Medical Officer at Nektar Therapeutics, a leading research-based biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need including treatments for cancer and auto-immune disease.\u00a0 Previously, she served as Chief Medical Officer and Chief Regulatory Officer for Kanglaite-USA and was Co-Founder, President and Board Member of Bionovo, Inc.\u00a0 She earned her Bachelor of Science degree at Cornell University and her medical degree at the University of California, San Francisco. Dr. Tagliaferri was named to the Women who Lead in Life Sciences and Most Influential Women in Business lists by the San Francisco Business Times in 2019 and was recognized as Woman of the Year, 2012, by the State of California, Assembly District 14.\u00a0 She has been lead author or contributor to approximately 70 journal publications.<\/p>\n<p align=\"justify\">\u201cI am very pleased to be joining the Enzo Board of Directors at a time that presents so many important opportunities for the company to continue to show innovation and leadership in response to the COVID-19 pandemic and other emerging health challenges,\u201d said Dr. Tagliaferri.\u00a0 \u201cI look forward to working closely with the members of the board and the Enzo leadership team to maximize the full range of business opportunities the company is targeting in the years ahead.\u201d<\/p>\n<p align=\"justify\">\u201cIn recent months, Enzo has announced many significant advances in our business strategy, including receipt of FDA Emergency Use Authorization for our GenFlex\u2122 platform for COVID-19 testing, expansion of our Farmingdale, New York facility, launch of our direct-to-consumer testing service, and the recent introduction of our microplate reader for use with our ELISA and assay kits,\u201d Dr. Rabbani added.\u00a0\u00a0 \u201cDr. Tagliaferri\u2019s outstanding experience will be an important resource for us to continue this momentum and identify and target a wide range of new strategic opportunities to expand our operations and address new areas of unmet need.\u201d<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dh48MqoliDpzf0nb6VTmT6HRpukMVVfVNN218_5fo0biNdLopj20HsJPNiS9dMtA6CwwvPTlvPwJ56w8mcGg_A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n            <u>About Enzo Biochem<\/u><br \/>\n          <\/a><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <br \/> \u00a0<\/strong><br \/>\n        <br \/>Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem\u2019s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Forward-Looking Statements<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Except for historical information, the matters discussed in this release may be considered &#8220;forward-looking&#8221; statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, inter alia, the markets for the Company\u2019s products and services, costs of goods and services, other expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Company\u2019s Form 10-K for the fiscal year ended July 31, 2020. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this release.<\/p>\n<p align=\"center\">###<\/p>\n<p align=\"left\">\n        \n      <\/p>\n<p>Contact:<\/p>\n<p>For Enzo Biochem, Inc.<\/p>\n<p>David Bench, CFO<br \/> 212-583-0100<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hOe7arCEgMG1AY4VA-1tnMKkYccQl4iDNRZp5BaqEIcjMJfDuizvWI6Dz3eT81kKlFIutxQtFNoPwjUaIIkzGg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>dbench@enzo.com<\/u><\/a><\/p>\n<p>Media:<\/p>\n<p>Marisa Monte\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Berry &amp; Company Public Relations<br \/>212-253-8881<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D9G2zPbLXLDl5uP5AT1vUmE911NcWe6v_goyjV32bnYdfvGTVHl7H2pr2nQBzdr9c-_0j-fZV6qkh4ZI-NRTtTNXNCWeruTFUehX4U54-lE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>mmonte@berrypr.com<\/u><\/a><\/p>\n<p>Investors:<\/p>\n<p>Jeremy Feffer<br \/>LifeSci Advisors, LLC<br \/>212-915-2568<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lkW3NhkfL-0t7IvYqY3ycmHJn9sgHXtGk8jq0yg7B85MVUoPRZVzDQOB1ECfcUU387oUn-hiSmsiThNWFMWaXZpHJpvM0i6_mF-fgiP3XXKYppCgOfi5B3eItAPqflRq\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>jeremy@lifesciadvisors.com<\/u><\/a><\/p>\n<p>Steve Anreder<br \/>Anreder &amp; Company<br \/>212-532-3232<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SlrcFosKpK1OJSFI-MPVNDstVOLfe1ftBu6VX4L4l8JmqjBvkGHgHPplBf-ahNiqAQ-0nZLWlPfJBKcan7F0xbrjH0y-j2Vgt1Qb0-QWhQPdljQFv1itUwIUYDMZSZQR\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Steven.anreder@anreder.com<\/u><\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8f6a11f2-990c-435d-aeb5-c90bf268f7f0\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, NY, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cthe Company\u201d), a leading biosciences and diagnostics company, announced today that Mary Tagliaferri, MD, has been appointed to the company\u2019s Board of Directors effective immediately.\u00a0\u00a0\u00a0 \u201cIn 2020, Enzo reported significant progress in advancing our business plan to achieve profitability including strong results in many areas of our operations that position us for new levels of growth and momentum in 2021,\u201d said Dr. Elazar Rabbani, Ph.D., Enzo\u2019s Chairman and Chief Executive Officer.\u00a0 \u201cDr. Tagliaferri is a highly-respected industry leader with broad global experience in a range of operational areas including business development, clinical research and development, world-wide regulatory matters and medical affairs. \u00a0She will play a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD,  TO ITS BOARD OF DIRECTORS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-383919","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, NY, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cthe Company\u201d), a leading biosciences and diagnostics company, announced today that Mary Tagliaferri, MD, has been appointed to the company\u2019s Board of Directors effective immediately.\u00a0\u00a0\u00a0 \u201cIn 2020, Enzo reported significant progress in advancing our business plan to achieve profitability including strong results in many areas of our operations that position us for new levels of growth and momentum in 2021,\u201d said Dr. Elazar Rabbani, Ph.D., Enzo\u2019s Chairman and Chief Executive Officer.\u00a0 \u201cDr. Tagliaferri is a highly-respected industry leader with broad global experience in a range of operational areas including business development, clinical research and development, world-wide regulatory matters and medical affairs. \u00a0She will play a &hellip; Continue reading &quot;ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-18T13:08:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS\",\"datePublished\":\"2020-11-18T13:08:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/\"},\"wordCount\":776,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/\",\"name\":\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==\",\"datePublished\":\"2020-11-18T13:08:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk","og_description":"NEW YORK, NY, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Enzo Biochem, Inc. (NYSE:ENZ) (\u201cEnzo\u201d or \u201cthe Company\u201d), a leading biosciences and diagnostics company, announced today that Mary Tagliaferri, MD, has been appointed to the company\u2019s Board of Directors effective immediately.\u00a0\u00a0\u00a0 \u201cIn 2020, Enzo reported significant progress in advancing our business plan to achieve profitability including strong results in many areas of our operations that position us for new levels of growth and momentum in 2021,\u201d said Dr. Elazar Rabbani, Ph.D., Enzo\u2019s Chairman and Chief Executive Officer.\u00a0 \u201cDr. Tagliaferri is a highly-respected industry leader with broad global experience in a range of operational areas including business development, clinical research and development, world-wide regulatory matters and medical affairs. \u00a0She will play a &hellip; Continue reading \"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-18T13:08:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS","datePublished":"2020-11-18T13:08:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/"},"wordCount":776,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/","name":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==","datePublished":"2020-11-18T13:08:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODQyOSMzODMzNjA1IzUwMDA3MTYzNQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/enzo-biochem-announces-appointment-of-mary-tagliaferri-md-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/383919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=383919"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/383919\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=383919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=383919"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=383919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}